CLINICAL OUTCOMES IN REAL-WORLD PATIENTS RECEIVING THE XIENCE V® EVEROLIMUS-ELUTING STENT PRESENTING WITH CHRONIC KIDNEY DISEASE: ONE-YEAR RESULTS FROM THE XIENCE V USA STUDY

被引:2
|
作者
Gruberg, Luis [1 ]
Jeremias, Allen [1 ]
Rutledge, David R. [1 ]
Mao, Vivian W. [1 ]
Zhao, Weiying [1 ]
Pechonkina, Alena V. [1 ]
Wang, Jin [1 ]
Wilburn, Olivia [1 ]
Sudhir, Krishnankutty [1 ]
Krucoff, Mitchell W. [1 ]
Hermiller, James B. [1 ]
机构
[1] SUNY Stony Brook, Med Ctr, Stony Brook, NY 11794 USA
关键词
D O I
10.1016/S0735-1097(11)61896-2
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:E1896 / E1896
页数:1
相关论文
共 50 条
  • [31] TWO-YEAR CLINICAL OUTCOMES OF THE NOBORI BIOLIMUS-ELUTING STENT AND XIENCE EVEROLIMUS-ELUTING STENT IN PATIENTS TREATED WITH IN-STENT RESTENOSIS
    Hiromasa, Takashi
    Kuramitsu, Shoichi
    Morinaga, Takashi
    Kobayash, Yohei
    Jinnouch, Hiroyuki
    Domei, Takenori
    Hyodo, Makoto
    Shirai, Shinichi
    Ando, Kenji
    Nobuyoshi, Masakiyo
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2015, 65 (10) : A1894 - A1894
  • [32] The SPIRIT V Study A Clinical Evaluation of the XIENCE V Everolimus-Eluting Coronary Stent System in the Treatment of Patients With De Novo Coronary Artery Lesions
    Grube, Eberhard
    Chevalier, Bernard
    Smits, Peter
    Dzavik, Vladimir
    Patel, Tejas M.
    Mullasari, Ajit S.
    Woehrle, Jochen
    Stuteville, Marrianne
    Dorange, Cecile
    Kaul, Upendra
    JACC-CARDIOVASCULAR INTERVENTIONS, 2011, 4 (02) : 168 - 175
  • [33] Stent Thrombosis after Implantation of XIENCE V Everolimus-Eluting Coronary Stent Systems in On-label and Off-label Populations: Pooled Two-Year Results from Seven XIENCE V Coronary Stent Trials
    Hermiller, James B.
    Rutledge, David R.
    Sudhir, Krishnankutty
    Stone, Gregg W.
    Serruys, Patrick W.
    Mao, Vivian W.
    Zhao, Weiying
    Yaqub, Manejeh
    Sood, Poornima
    Wang, Jin
    Cao, Sherry
    Zheng, Qing
    Jonnavithula, Lalitha K.
    Simonton, Charles A.
    Krucoff, Mitchell W.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2011, 58 (20) : B23 - B23
  • [34] 5-Year Results of a Randomized Comparison of XIENCE V Everolimus-Eluting and TAXUS Paclitaxel-Eluting Stents Final Results From the SPIRIT III Trial (Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent System in the Treatment of Patients With De Novo Native Coronary Artery Lesions)
    Gada, Hemal
    Kirtane, Ajay J.
    Newman, William
    Sanz, Mark
    Hermiller, James B.
    Mahaffey, Kenneth W.
    Cutlip, Donald E.
    Sudhir, Krishnankutty
    Hou, Liming
    Koo, Kai
    Stone, Gregg W.
    JACC-CARDIOVASCULAR INTERVENTIONS, 2013, 6 (12) : 1263 - 1266
  • [35] Procedural and One-Year Clinical Outcomes of Long 48 mm Xience Xpedition Everolimus-Eluting Stent in Complex Long Diffuse Coronary Artery Lesions
    Hsiao, Fu-Chih
    Tsai, Cheng-Ting
    Hsu, Lung-An
    Tung, Ying-Chang
    Yu, Fa-Chang
    Lin, Chia-Pin
    Chou, Shing-Hsien
    Lee, Hsin-Fu
    Lin, Yen-Chen
    Chang, Chi-Jen
    JOURNAL OF INVASIVE CARDIOLOGY, 2022, 34 (02): : E80 - E86
  • [36] Five-year clinical outcomes of everolimus-eluting stents from the post marketing study of CoCr-EES (XIENCE V/PROMUS) in Japan
    Jiro Aoki
    Ken Kozuma
    Masaki Awata
    Mamoru Nanasato
    Nobuo Shiode
    Kengo Tanabe
    Junichi Yamaguchi
    Hajime Kusano
    Hong Nie
    Takeshi Kimura
    Cardiovascular Intervention and Therapeutics, 2019, 34 : 40 - 46
  • [37] Five-year clinical outcomes of everolimus-eluting stents from the post marketing study of CoCr-EES (XIENCE V/PROMUS) in Japan
    Aoki, Jiro
    Kozuma, Ken
    Awata, Masaki
    Nanasato, Mamoru
    Shiode, Nobuo
    Tanabe, Kengo
    Yamaguchi, Junichi
    Kusano, Hajime
    Nie, Hong
    Kimura, Takeshi
    CARDIOVASCULAR INTERVENTION AND THERAPEUTICS, 2019, 34 (01) : 40 - 46
  • [38] The Everolimus-Eluting Stent in Real-World Patients 6-Month Follow-Up of the X-SEARCH (Xience V Stent Evaluated at Rotterdam Cardiac Hospital) Registry
    Onuma, Yoshinobu
    Kukreja, Neville
    Piazza, Nicolo
    Eindhoven, Jannet
    Girasis, Chrysafios
    Schenkeveld, Lisanne
    van Domburg, Ron
    Serruys, Patrick W.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2009, 54 (03) : 269 - 276
  • [39] 1-Year Outcomes of Everolimus-Eluting Bioresorbable Scaffolds Versus Everolimus-Eluting Stents A Propensity-Matched Comparison of the GHOST-EU and XIENCE V USA Registries
    Tamburino, Corrado
    Capranzano, Piera
    Gori, Tommaso
    Latib, Azeem
    Lesiak, Maciej
    Nef, Holger
    Caramanno, Giuseppe
    Naber, Christopher
    Mehilli, Julinda
    Di Mario, Carlo
    Sabate, Manel
    Muenzel, Thomas
    Colombo, Antonio
    Araszkiewicz, Aleksander
    Wiebe, Jens
    Geraci, Salvatore
    Jensen, Christoph
    Mattesini, Alessio
    Brugaletta, Salvatore
    Capodanno, Davide
    JACC-CARDIOVASCULAR INTERVENTIONS, 2016, 9 (05) : 440 - 449
  • [40] Low Stent Thrombosis Risk with the XIENCE V® Everolimus-Eluting Coronary Stent: Evidence from Randomized and Single-Arm Clinical Trials
    Bezenek, Susan
    Hermiller, James
    Lansky, Alexandra
    Yaqub, Manejeh
    Hattori, Kyoko
    Cao, Sherry
    Sood, Poornima
    Sudhir, Krishnakutty
    JOURNAL OF INTERVENTIONAL CARDIOLOGY, 2011, 24 (04) : 326 - 341